FIELD: biotechnology.
SUBSTANCE: strain of Lactobacillus paracasei spp. Paracasei LPC 09 DSM 24243 bacteria is proposed, which decomposes oxalic acid and/or its salts. The use of a pharmaceutical composition for prevention or therapeutic treatment of hyperoxaluria, urolithiasis, renal failure, cardiopathies, kidney stones, diverticulosis and diverticulitis is proposed. At that, the pharmaceutical composition comprises a bacterial composition comprising a plurality of cells of at least one bacterial strain, wherein at least one bacterial strain is Lactobacillus paracasei spp. paracasei LPC 09 DSM 24243. A food composition comprising a bacterial composition comprising a plurality of cells of at least one bacterial strain, wherein at least one bacterial strain is Lactobacillus paracasei spp. paracasei LPC 09 DSM 24243 is also provided.
EFFECT: effective decomposition of oxalic acid or its salt in an amount of more than 60 percent.
10 cl, 5 dwg, 2 tbl
